LncRNAs regulates cell death in osteosarcoma

Abstract Despite improvements, prognosis in osteosarcoma patients remains poor, making it essential to identify additional and more robust therapeutic targets. Non-apoptotic receptor-mediated cell death (RCD), which plays a crucial role in the pathogenesis of OS, is one avenue actively pursued as an...

Full description

Saved in:
Bibliographic Details
Main Authors: Ping’an Zou, Zhiwei Tao, Zhengxu Yang, Tao Xiong, Zhi Deng, Qincan Chen, Li Niu
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-04440-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849402611958022144
author Ping’an Zou
Zhiwei Tao
Zhengxu Yang
Tao Xiong
Zhi Deng
Qincan Chen
Li Niu
author_facet Ping’an Zou
Zhiwei Tao
Zhengxu Yang
Tao Xiong
Zhi Deng
Qincan Chen
Li Niu
author_sort Ping’an Zou
collection DOAJ
description Abstract Despite improvements, prognosis in osteosarcoma patients remains poor, making it essential to identify additional and more robust therapeutic targets. Non-apoptotic receptor-mediated cell death (RCD), which plays a crucial role in the pathogenesis of OS, is one avenue actively pursued as an alternative therapeutic target in OS. Long non-coding RNAs (lncRNAs) also play a diverse role in OS pathogenesis, and numerous studies have shown that they are attractive therapeutic targets in OS. However, whether lncRNA also plays a role in non-apoptotic RCD in OS is currently unknown. The objective of the current study was to identify if a functional lncRNA-based gene signature exists that regulates non-apoptotic RCD. We systematically screened immune-related lncRNAs associated with ferroptosis, necroptosis, and pyroptosis using the Pearson correlation algorithm (|Pearson R|> 0.4, P < 0.01) on 88 osteosarcoma patients and 122 normal controls that were selected from the TARGET and GETx databases. Univariate Cox regression analysis was employed to identify lncRNAs associated with osteosarcoma treatment. Three machine learning algorithms—Support Vector Machine, Random Forest, and Generalized Linear Model—were utilized to select feature genes. In low- and high-risk groups, immune infiltration was analyzed using CIBERSORT and gene set enrichment analysis. To verify the mechanism of signature lncRNAs, proteins related to pyroptosis, ferroptosis, and necroptosis were assessed via a combination of in vitro assays. LASSO regression analysis led to constructing a prognostic risk model consisting of four lncRNAs: AC006033.2, AC124798.1, LINC01517, and L3MBTL4-AS1. The AUC values for 1-, 3-, and 5-year survival in the testing set were 0.739, 0.809, and 0.708, respectively, while in the entire cohort, the AUC values were 0.849, 0.881, and 0.776, respectively, indicating high reliability and accuracy of the risk model. The high-risk group exhibited a worse prognosis. Five clusters were identified through non-negative matrix factorization clustering, revealing differences in immune infiltration and the tumor microenvironment. Quantitative polymerase chain reaction analysis showed that four lncRNAs were highly expressed in osteosarcoma, with LINC01517 being particularly associated with poor prognosis. Notably, silencing LINC01517 inhibited in vitro cell proliferation, activated NLRP3/caspase-1/GSDMD-mediated pyroptosis, promoted ferroptosis, and enhanced necroptosis in osteosarcoma cells. The non-apoptotic RCD-related lncRNA signature identified in this study provides valuable insights that will aid future exploration of these prognostic biomarkers as potential therapeutic targets for osteosarcoma treatment.
format Article
id doaj-art-906ae0c8342b437cbe56ad18b07628e4
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-906ae0c8342b437cbe56ad18b07628e42025-08-20T03:37:30ZengNature PortfolioScientific Reports2045-23222025-07-0115111510.1038/s41598-025-04440-3LncRNAs regulates cell death in osteosarcomaPing’an Zou0Zhiwei Tao1Zhengxu Yang2Tao Xiong3Zhi Deng4Qincan Chen5Li Niu6Bone and Soft Tissue Sarcoma Department, Jiangxi Cancer HospitalBone and Soft Tissue Sarcoma Department, Jiangxi Cancer HospitalBone and Soft Tissue Sarcoma Department, Jiangxi Cancer HospitalBone and Soft Tissue Sarcoma Department, Jiangxi Cancer HospitalBone and Soft Tissue Sarcoma Department, Jiangxi Cancer HospitalBone and Soft Tissue Sarcoma Department, Jiangxi Cancer HospitalCheerLand Clinical Laboratory Co., Ltd., Peking University Medical Industrial Park, Zhongguancun Life Science ParkAbstract Despite improvements, prognosis in osteosarcoma patients remains poor, making it essential to identify additional and more robust therapeutic targets. Non-apoptotic receptor-mediated cell death (RCD), which plays a crucial role in the pathogenesis of OS, is one avenue actively pursued as an alternative therapeutic target in OS. Long non-coding RNAs (lncRNAs) also play a diverse role in OS pathogenesis, and numerous studies have shown that they are attractive therapeutic targets in OS. However, whether lncRNA also plays a role in non-apoptotic RCD in OS is currently unknown. The objective of the current study was to identify if a functional lncRNA-based gene signature exists that regulates non-apoptotic RCD. We systematically screened immune-related lncRNAs associated with ferroptosis, necroptosis, and pyroptosis using the Pearson correlation algorithm (|Pearson R|> 0.4, P < 0.01) on 88 osteosarcoma patients and 122 normal controls that were selected from the TARGET and GETx databases. Univariate Cox regression analysis was employed to identify lncRNAs associated with osteosarcoma treatment. Three machine learning algorithms—Support Vector Machine, Random Forest, and Generalized Linear Model—were utilized to select feature genes. In low- and high-risk groups, immune infiltration was analyzed using CIBERSORT and gene set enrichment analysis. To verify the mechanism of signature lncRNAs, proteins related to pyroptosis, ferroptosis, and necroptosis were assessed via a combination of in vitro assays. LASSO regression analysis led to constructing a prognostic risk model consisting of four lncRNAs: AC006033.2, AC124798.1, LINC01517, and L3MBTL4-AS1. The AUC values for 1-, 3-, and 5-year survival in the testing set were 0.739, 0.809, and 0.708, respectively, while in the entire cohort, the AUC values were 0.849, 0.881, and 0.776, respectively, indicating high reliability and accuracy of the risk model. The high-risk group exhibited a worse prognosis. Five clusters were identified through non-negative matrix factorization clustering, revealing differences in immune infiltration and the tumor microenvironment. Quantitative polymerase chain reaction analysis showed that four lncRNAs were highly expressed in osteosarcoma, with LINC01517 being particularly associated with poor prognosis. Notably, silencing LINC01517 inhibited in vitro cell proliferation, activated NLRP3/caspase-1/GSDMD-mediated pyroptosis, promoted ferroptosis, and enhanced necroptosis in osteosarcoma cells. The non-apoptotic RCD-related lncRNA signature identified in this study provides valuable insights that will aid future exploration of these prognostic biomarkers as potential therapeutic targets for osteosarcoma treatment.https://doi.org/10.1038/s41598-025-04440-3OsteosarcomalncRNANon-apoptotic receptor-mediated cell deathRCDFerroptosis
spellingShingle Ping’an Zou
Zhiwei Tao
Zhengxu Yang
Tao Xiong
Zhi Deng
Qincan Chen
Li Niu
LncRNAs regulates cell death in osteosarcoma
Scientific Reports
Osteosarcoma
lncRNA
Non-apoptotic receptor-mediated cell death
RCD
Ferroptosis
title LncRNAs regulates cell death in osteosarcoma
title_full LncRNAs regulates cell death in osteosarcoma
title_fullStr LncRNAs regulates cell death in osteosarcoma
title_full_unstemmed LncRNAs regulates cell death in osteosarcoma
title_short LncRNAs regulates cell death in osteosarcoma
title_sort lncrnas regulates cell death in osteosarcoma
topic Osteosarcoma
lncRNA
Non-apoptotic receptor-mediated cell death
RCD
Ferroptosis
url https://doi.org/10.1038/s41598-025-04440-3
work_keys_str_mv AT pinganzou lncrnasregulatescelldeathinosteosarcoma
AT zhiweitao lncrnasregulatescelldeathinosteosarcoma
AT zhengxuyang lncrnasregulatescelldeathinosteosarcoma
AT taoxiong lncrnasregulatescelldeathinosteosarcoma
AT zhideng lncrnasregulatescelldeathinosteosarcoma
AT qincanchen lncrnasregulatescelldeathinosteosarcoma
AT liniu lncrnasregulatescelldeathinosteosarcoma